Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.
暂无分享,去创建一个
D. Baim | D. Cohen | C. Gibson | M. Moscucci | R. Kuntz | J. Carrozza | R. Piana | A. Kugelmass | G. Paik | Gibson Cm | D. Cohen | Rn Piana | GY Paik | Jr Jp Carrozza | D. Cohen
[1] A. Kitabatake,et al. Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.
[2] J. Shani,et al. Early and late angiographic findings of the "no-reflow" phenomenon following direct angioplasty as primary treatment for acute myocardial infarction. , 1992, American heart journal.
[3] D. Baim,et al. Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. , 1991, Catheterization and cardiovascular diagnosis.
[4] R. Kloner,et al. Experimental infarct size reduction with calcium channel blockers. , 1991, Journal of the American College of Cardiology.
[5] D. Harrison,et al. L-cysteine selectively potentiates nitroglycerin-induced dilation of small coronary microvessels. , 1991, The Journal of pharmacology and experimental therapeutics.
[6] M. Marcus,et al. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. , 1991, Circulation research.
[7] D. Harrison,et al. Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. , 1990, American Journal of Physiology.
[8] R. Kloner,et al. Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi? , 1989, Circulation.
[9] C. White,et al. INTENSE MICROVASCULAR CONSTRICTION AFTER ANGIOPLASTY OF ACUTE THROMBOTIC CORONARY ARTERIAL LESIONS , 1989, The Lancet.
[10] M. Rosolowsky,et al. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. , 1989, Circulation.
[11] V. Fuster,et al. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. , 1987, Circulation.
[12] E. Braunwald,et al. Effect of verapamil on infarct size in dogs subjected to coronary artery occlusion with transient reperfusion. , 1986, Journal of the American College of Cardiology.
[13] L Roy,et al. Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.
[14] W. O’Neill,et al. Demonstration of the "no-reflow" phenomenon by digital coronary arteriography. , 1986, The American journal of cardiology.
[15] J. Schofer,et al. Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis. , 1985, Journal of the American College of Cardiology.
[16] R. Kloner,et al. The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion. , 1984, Circulation.
[17] R. Kloner,et al. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.
[18] M. Winbury,et al. Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates. , 1969, The Journal of pharmacology and experimental therapeutics.